Cellebrite DI Ltd Ordinary Shares CLBT 深 滬
等待開盤 10-02 09:30:00 美东时间
18.50
-0.030
-0.16%
華盛通- 最 高18.68
- 今 開18.40
- 成交量 98.68万股
- 最 低 18.16
- 昨 收 18.53
- 總市值 44.22亿
- 52周最高 26.30
- 市盈率 靜 --
- 換手率 0.41%
- 52周最低 13.10
- 委 比 -21.79%
- 總股本 2.39亿
- 歷史最高 26.30
- 量 比 0.55
- 振 幅 2.81%
- 歷史最低 3.80
- 每 手 1
- 風險率 2.67%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 217美元！花旗上调阿里巴巴目标价；多家机构集体上调麦克森、美光科技等目标价
今日重点评级关注：Ascendiant Capital：维持Maison Solutions"买入"评级，目标价从4美元升至4.25美元；瑞穗：维持MBX Biosciences"跑赢大市"评级，目标价从38美元升至56美元
09-25 09:52
JP Morgan Maintains Overweight on Cellebrite DI, Raises Price Target to $23
JP Morgan analyst Brian Essex maintains Cellebrite DI (NASDAQ:CLBT) with a Overweight and raises the price target from $20 to $23.
09-24 20:30
美股大行评级 | 潜在涨幅仍有782.74%！Passage BIO遭Canaccord Genuity下调目标价至67美元，维持"买入"评级
今日重点评级关注：Northland Capital Markets：维持BrainsWay"跑赢大市"评级，目标价从15美元升至19美元；Lake Street：维持Hyperfine"买入"评级，目标价从1.5美元升至2美元
08-15 09:30
Needham Maintains Buy on Cellebrite DI, Lowers Price Target to $18
Needham analyst Mike Cikos maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $24 to $18.
08-15 01:44
Cellebrite shares are trading higher after the company reported better-than-expected Q2 financial results.
Cellebrite shares are trading higher after the company reported better-than-exp...
08-14 22:10
Cellebrite DI Sees Q3 Sales $121.000M-$126.000M vs $124.357M Est
Cellebrite DI (NASDAQ:CLBT) sees Q3 sales of $121.000 million-$126.000 million vs $124.357 million analyst estimate.
08-14 19:03
Earnings Scheduled For August 14, 2025
Companies Reporting Before The Bell • Sunlands Technology (NYSE:STG) is likely ...
08-14 16:32
U.S. Department of Justice to Sponsor Cellebrite for FedRAMP ATO
Cellebrite announced U.S. Department of Justice (DOJ) sponsorship to advance its Cellebrite Government Cloud (CGC) from FedRAMP High Ready to "In Process" status, a key step toward full Authorization to Operate (ATO). CGC will offer secure, cutting-edge cloud solutions, including Cellebrite Inseyets and Guardian, enhancing investigative workflows and operational efficiency for U.S. federal agencies.
07-23 12:30
Cellebrite Appoints David Barter as New CFO
The latest update is out from Cellebrite DI ( ($CLBT) ). Cellebrite announced t...
07-08 21:17
Cellebrite Names David Barter Chief Financial Officer
Cellebrite announced the appointment of David Barter as its new Chief Financial Officer, succeeding Dana Gerner, who is retiring after 11 years in the role. Barter brings over 30 years of experience in scaling global software companies, most recently at New Relic, where he helped drive growth to nearly $1 billion in annual revenue. Gerner will remain in an advisory role until the company reports its second-quarter 2025 financial results. Barter w...
07-08 12:30
